COVID-19 vaccines for very young children

UC Riverside vaccine expert David Lo shares his thoughts in a Q&A

UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID

SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants

By Iqbal Pittalwala | | Health

Should you get a second booster shot for COVID-19?

UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts

By Iqbal Pittalwala | | Health

A potential antiviral for SARS and SARS-like coronaviruses

UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed

By Iqbal Pittalwala | | Health

Scientists profile FDA-approved drugs to potentially treat hundreds of genetic disorders

New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders

By Iqbal Pittalwala | | Health

Researchers develop molecular traps to target SARS-CoV-2

Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells

By Iqbal Pittalwala | | Health

Scientists discover new avian immunological pathway

UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines

By Iqbal Pittalwala | | Health

Building robust collaborations to ‘ATTACK’ future pandemics

As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...

By UCR News | | Health

A more targeted therapy to treat inflammatory bowel disease

UC Riverside mouse study focuses on the receptor TNFR1

By Iqbal Pittalwala | | Health

New hope for people living with a genetic cause of autism

UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome

By Iqbal Pittalwala | | Health

How sepsis need not be fatal

UC Riverside-led team identifies molecular driver and protector of this life-threatening medical emergency

By Iqbal Pittalwala | | Health

Public lecture to focus on synthetic genome engineering

Lei Stanley Qi of Stanford University will give the 2021 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside

By Iqbal Pittalwala | | Health

Novel mechanism links genetic defect in IBD patients to gut leakiness

UC Riverside-led study in mice and human tissue is the first to show how a disease mutation weakens barrier properties of epithelial cells lining the gut

By Iqbal Pittalwala | | Health

How concerned should we be about the Delta variant?

UC Riverside experts share their thoughts

By Iqbal Pittalwala | | Health

Salton Sea aerosol exposure triggers unique and mysterious pulmonary response

UC Riverside mouse study suggests inflammation could play key role in progression to asthma

By Iqbal Pittalwala | | Health

New method expands the world of small RNAs

PANDORA sequencing method developed by UC Riverside-led team can detect once-undetectable small RNAs

How the South African COVID-19 variant was found

UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain

By Iqbal Pittalwala | | Health

What UC Riverside scientists have to say about vaccines, variants, and antibodies

Immunity generated by vaccination is better than immunity from an actual infection, says an expert

By Iqbal Pittalwala | | Health

Remyelinating drug could improve vision in patients with multiple sclerosis

UC Riverside-led mouse study stresses MS treatment should be started early

By Iqbal Pittalwala | | Health

Biomedical scientist explains how Covid-19 vaccines work

Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines

By Iqbal Pittalwala | | Health